OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Internal Medicine is 41. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
The Mediterranean diet and health: a comprehensive overview	321
Ambient air pollution and cardiovascular diseases: An umbrella review of systematic reviews and meta‐analyses	216
Prevalence and 6‐month recovery of olfactory dysfunction: a multicentre study of 1363 COVID‐19 patients	167
Short‐term neuropsychiatric outcomes and quality of life in COVID‐19 survivors	149
Homocysteine – from disease biomarker to disease prevention	127
Immunity to SARS‐CoV‐2 induced by infection or vaccination	105
Breathing, speaking, coughing or sneezing: What drives transmission of SARS‐CoV‐2?	105
Nanotechnology for modern medicine: next step towards clinical translation	102
Advances in the Omicron variant development	101
Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer’s disease (MCI and dementia) in primary care: a review and synthesis	99
Current treatment of non‐alcoholic fatty liver disease	99
Insights into disparities observed with COVID‐19	97
How can dementia and disability be prevented in older adults: where are we today and where are we going?	87
Direct oral anticoagulant use and risk of severe COVID‐19	76
Lessons from 20 years with COX‐2 inhibitors: Importance of dose–response considerations and fair play in comparative trials	69
Association of mitochondrial DNA copy number with metabolic syndrome and type 2 diabetes in 14 176 individuals	68
Pediatric obesity—Long‐term consequences and effect of weight loss	67
Arterial stiffness in acute COVID‐19 and potential associations with clinical outcome	63
Deep brain stimulation for Parkinson's disease	59
Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's disease	59
Current concepts regarding Graves’ orbitopathy	59
Genetics of coronary artery disease in the post‐GWAS era	57
Current and emerging disease‐modulatory therapies and treatment targets for multiple sclerosis	57
Adherence to a healthy sleep pattern is associated with lower risks of all‐cause, cardiovascular and cancer‐specific mortality	56
Diagnosis and management of diabetes insipidus for the internist: an update	56

Hypocretins (orexins): The ultimate translational neuropeptides	55
Inflammatory and fibrotic mechanisms in NAFLD—Implications for new treatment strategies	53
Alveolar progenitor cells and the origin of lung cancer	53
The role of environmental exposures and gene–environment interactions in the etiology of systemic lupus erythematous	52
Type 2 diabetes and remission: practical management guided by pathophysiology	50
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID‐19	48
Long‐term neuropsychiatric outcomes in COVID‐19 survivors: A 1‐year longitudinal study	47
Assessment of thirty‐day readmission rate, timing, causes and predictors after hospitalization with COVID‐19	45
Acute odynophagia: A new symptom of COVID‐19 during the SARS‐CoV‐2 Omicron variant wave in Sweden	44
Respiratory dysfunction three months after severe COVID‐19 is associated with gut microbiota alterations	44
Hypoalbuminemia in COVID‐19: assessing the hypothesis for underlying pulmonary capillary leakage	44
Epigenetic aging: Biological age prediction and informing a mechanistic theory of aging	44
The Stockholm CREAtinine Measurements (SCREAM) project: Fostering improvements in chronic kidney disease care	43
Gender‐affirming hormone therapy: An updated literature review with an eye on the future	43
Review of cadmium exposure and smoking‐independent effects on atherosclerotic cardiovascular disease in the general population	42
Food allergy and hypersensitivity reactions in children and adults—A review	42
Half‐year follow‐up of patients recovering from severe COVID‐19: Analysis of symptoms and their risk factors	41
Increased vulnerability to COVID‐19 in chronic kidney disease	41
Gastrointestinal bleeding in hospitalized COVID‐19 patients: a propensity score matched cohort study	41